Nanosphere is advancing health care with innovative diagnostic tools that empower clinicians to make faster, better-informed treatment decisions for their patients. More

Verigene Clinical Microbiology Tests

Nucleic acid-based detection of infectious disease agents in clinical microbiology diagnostics. Gold nanoparticle probe technology: multiplex detection of amplified and non-amplified infectious disease targets.

 

Verigene Cardiac Tests

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.

Verigene Human Genetic Tests

The detection of single nucleotide polymorphisms (SNPs) and similar DNA sequence variations plays an important role in the identification of individual’s who are at risk for having an inherited genetic disorder or are at risk for passing on a disorder to offspring.

Verigene Pharmacogenetic Tests

Pharmacogenetics: genetic variation with differing response to drugs. Gold nanoparticle probe technology enables multitarget detection of single nucleotide polymorphism (SNPs) and similar DNA sequence variations that alter an individual’s metabolism of specific drugs.

Verigene Instruments

International Distributors

Nanosphere at asm2012

Visit Nanosphere at booth 1008 in the exhibit area at the American Society for Microbiology (ASM) Annual Meeting.

June 17-19 | San Francisco, CA

 

Nanosphere Receives FDA Clearance of Gram-Positive Blood Culture Test for Staphylococcus

Nanosphere announced it has received FDA clearance for its Staphylococcus Blood Culture Nucleic Acid Test (BC-S) on the automated sample-to-result Verigene System.

Technical Support